Jennifer Doudna

Scientists from UC Berkeley are part of a research team using Nobel Prize-winning CRISPR technology to develop a COVID-19 diagnostic test that is fast, convenient and can be performed on site.

Forbes 50 Over 50 list featured two members of the UC Berkeley community to recognize the impact of their work.

UC Berkeley will auction two nonfungible tokens, or NFTs, relating to Nobel Prize-winning inventions for the funding of future research and innovation.

CRISPR genome editing technology, which was developed at UC Berkeley, has been approved for clinical trials to correct gene mutations responsible for sickle cell disease.

It’s been a tough year, to say the least, yet women and gender-nonconforming folks have continued to persevere, fight back and overcome the odds stacked against them.

Researchers from UC Berkeley and Gladstone Institutes have developed a technology that could detect the coronavirus in five minutes based on Nobel Prize-winning CRISPR technology.

UC Berkeley's Innovative Genomics Institute, or IGI's, Free Asymptomatic Saliva Test, or FAST, study for COVID-19 will end Thursday after having tested more than 4,800 people, according Jennifer Doudna, president and chair of the IGI governance board

In the wake of the news that UC Berkeley’s spring 2021 semester will consist of mostly remote instruction, Berkeley Conversations hosted a panel of professors Monday to address the factors affecting the campus's reopening.

Jennifer Doudna, UC Berkeley professor of chemistry, biochemistry and molecular biology, was awarded half of the Nobel Prize in chemistry Wednesday for developing the gene-editing technology CRISPR-Cas9.

In an effort to speed up COVID-19 testing, researchers at UC Berkeley and UCSF are using robotics to test hundreds of samples every day.